Touching tumour‐infiltrating lymphocytes in low‐risk ductal carcinoma in situ (DCIS) correlate with upgrading to high‐grade DCIS
Author:
Affiliation:
1. Department of Pathology Roswell Park Comprehensive Cancer Center BuffaloNYUSA
2. Department of Radiology Roswell Park Comprehensive Cancer Center BuffaloNYUSA
3. Department of Biostatistics Roswell Park Comprehensive Cancer Center Buffalo NY USA
Funder
Center for Strategic Scientific Initiatives, National Cancer Institute
Publisher
Wiley
Subject
General Medicine,Histology,Pathology and Forensic Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/his.14539
Reference32 articles.
1. The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)
2. Surgical Upstaging Rates for Vacuum Assisted Biopsy Proven DCIS: Implications for Active Surveillance Trials
3. De-Escalation of Locoregional Therapy in Low-Risk Disease for DCIS and Early-Stage Invasive Cancer
4. De-Escalating Breast Cancer Surgery for Low-Risk Ductal Carcinoma in Situ—Reply
5. Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Stromal lymphocytes are associated with upgrade of B3 breast lesions;Breast Cancer Research;2024-07-08
2. Emerging measurements for tumor-infiltrating lymphocytes in breast cancer;Japanese Journal of Clinical Oncology;2024-03-23
3. A single-arm study design with non-inferiority and superiority time-to-event endpoints: a tool for proof-of-concept and de-intensification strategies in breast cancer;Frontiers in Oncology;2023-07-11
4. Utility of stromal lymphocytes in diagnosis and predicting upgrade of B3 breast lesions from core biopsies;2022-09-05
5. Preneoplastic Low-Risk Mammary Ductal Lesions (Atypical Ductal Hyperplasia and Ductal Carcinoma In Situ Spectrum): Current Status and Future Directions;Cancers;2022-01-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3